The use of interferon beta at the time of initial diagnosis of multiple sclerosis.
Pender
M P
MP
Department of Medicine, The University of Queensland, Queensland, Australia.
D000276:Adjuvants, Immunologic / Q000627:therapeutic use*; D006801:Humans; D016899:Interferon-beta / Q000627:therapeutic use*; D009103:Multiple Sclerosis / Q000175:diagnosis / Q000188:drug therapy*
D000276:Adjuvants, Immunologic; D016899:Interferon-beta